DO-10

Indicaton

GM1-gangliosidosis and mucopolysaccharidosis IVB, 2 rare diseases caused by beta-galactosidase deficiency.

Therapeutic indications

Metabolic disorder

Type of product

Small molecule

Table

Phase

Discovery
Available in

EU, US, Japan

You may also be interested in

OligoPhore / SemaPhore / CycloPhore Peptide-Based RNA Delivery Platforms

Delivers siRNA, antisense oligonucleotides, linear or circular mRNA and other RNA modalities to extrahepatic tissues - demonstrated across various indications in oncology (e.g. PDAC, breast cancer, ovarian cancer, lung cancer, melanoma, ATLL, TME), and inflammatory / autoimmune diseases (e.g. OA, RA, enterocolitis), CV (e.g. atherosclerosis, aortic aneurysm)

Discovery

LakeSai – Accelerating Discovery with AI You Can Trust

LakeSAI is a membership-based AI research agent built for scientists who need faster, deeper and more transparent access to biomedical knowledge. Users interact via natural language or structured data inputs, enabling precise, reproducible and evidence-based exploration. Explore: https://lakesai.vitafluence.com

Discovery

Sublingual semaglutide

obesity and diabetes

Discovery